focus -WSS

focus

author：focus 2025-09-08 08:52:57 - browse：82365

Smartphone & medicine illustration — Alex Hogan/STAT

Pear Therapeutics may be gone, but one of its most important deals is still driving critical conversations about how medical apps can find a foothold in the slow-moving health care system.

In recent months, representatives of the Massachusetts state Medicaid program, MassHealth, have been presenting data suggesting reSET and reSET-O, Pear’s prescription apps that treat substance use disorder and opioid use disorder, saved the state money over a one-year period from 2021 to 2022. The data, which take into account health care utilization before and after people used the apps, have been presented to policymakers considering how to cover novel digital health products and shown to lawmakers considering federal legislation that would require Medicare coverage for prescription apps.

Pear, which filed for bankruptcy earlier this year, was one of the leading companies marketing prescription digital therapeutics, or Food and Drug Administration-cleared apps designed to treat disease. Pear’s reSET was the first such app cleared by the FDA in 2017.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Biden will tout long

leisure time

WSS

Elon Musk says he may need surgery before proposed 'cage match' with Mark Zuckerberg

Why workplace violence is so common in health care

First transplant of an entire human eye performed

Thousands of Marines and sailors deploy to Middle East to deter Iran from seizing ships

Healthy food access boosts outcomes in two studies

Trump Jan. 6 attorney John Lauro is ex

hotspot

focus

leisure time

Medical records are filled with copy

At least 12 people were injured in a blast at a port in northwest Turkey

As demand for Covid shots wanes, Moderna seeks its next success

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

Medical leaders decry Supreme Court decision on affirmative action

The UK government moves asylum

Psychedelics group wrestles with new pharma identity

Israel demolishes home of alleged Palestinian attacker, fueling West Bank tensions

Anesthesiologist group: stop taking Ozempic before surgery

'The Exorcist' director William Friedkin dead at 87

focus

Mississippi candidates for statewide offices square off in party primaries

How state and local governments are sidelining science

What is STAT's opinion section for?

Trump Jan. 6 attorney John Lauro is ex

Today's health inequities arise from racist U.S. history, say experts

Experimental asthma app from Apple and Anthem shows promise

knowledge

explore

leisure time

hotspot